What mechanism do immunosuppressants use to help manage SLE?

Immunosuppressants are used in the management of systemic lupus erythematosus (SLE) by decreasing immune system activity. SLE is characterized by an overactive immune response, in which the body mistakenly attacks its own tissues. This hyperactivity contributes to the inflammation and damage associated with the disease.

By using immunosuppressants, the aim is to reduce this overactive immune response, which in turn helps to limit the inflammatory processes involved in SLE. This reduction in immune activity can help decrease symptoms, prevent flare-ups, and protect organs from damage caused by the autoimmune attack.

In contrast, promoting inflammation or enhancing the immune response would exacerbate the condition and lead to worsening symptoms. Additionally, while immunosuppressants can help manage SLE, they do not prevent all diseases, as they are specifically designed to target the dysregulated immune activity associated with autoimmune conditions like lupus.